🔗 Share this article

An underground market for unapproved slimming medications is propelled by social media fitness personalities and sellers on communication apps, based on new investigations.

Investigational Drug Gaining Traction Online

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Followers are encouraged to contact these profiles privately for source information, while also obtaining promotional offers.

Thriving Trade on Social Networks

Additionally, a robust market exists on Telegram, where communities with numerous of participants share “before and after” photos, administration instructions and assertions of rapid British shipping. Vendors market the drug there before redirecting customers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Medical Experts Express Concerns

Nevertheless, physicians and chemists have cautions that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to individuals injecting substances of unknown origin.

Some professionals said the popularity for the experimental drug could be linked to the rising price of licensed slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for personal consumption under the British medical regulations.

Several content creators attempt to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach pharmaceutical, marketing, and customer regulations, risking penalties, legal action or prison.

Platform Reaction and Content Removal

Based on TikTok, the service has taken down violative material and prohibited associated hashtags and query recommendations. The organization stated it was dedicated to keeping the platform safe and investing in strengthening compliance measures.

Digital Trading Operations

Investigations also discovered communities with up to 9,000 participants marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately displays channels with numerous of members, filled with photos of slimming results, glowing testimonials and detailed guides for preparing or injecting at residence.

Within moments of joining one group, a seller shared WhatsApp details, where most purchases occur. The vendor sent an instruction manual and promised delivery within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about body mass, health issues or previous experience.

Product Information and Pricing

Within these communities, posts show dark colored packages with Royal Mail stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20mg. When asked how long a pen should last, sellers give conflicting answers varying between a several days to “depends on your body”.

Platform Oversight and Security Measures

A representative for the messaging service stated it regularly moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting materials they can’t verify. Even if the science behind this drug is sound, these online products may not contain what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.

Her team has already seen individuals injured by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly said the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a company experimental product not yet authorized … may subject users to possibly significant health risks”.